Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Astra Zeneca
Woman
Between 18 years
and 99 years
Astra Zeneca
Update Il y a 4 ans
Astra Zeneca D5392L00013 : Essai de phase 4 évaluant les désordres articulaires sous anatrozole chez des patientes ménopausées ayant un cancer du sein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A Multicentre, Open Study Assessing Joint Disorders Under ARIMIDEX® (1mg/Day) as Adjuvant Treatment in Post Menopausal Women With Early Breast Cancer.
Country
France
organs
Sein
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman
Between 18 years
and 99 years
Astra Zeneca
Update Il y a 4 ans
AZ D0810C00019 : Essai de phase 2 randomisé, en double aveugle, évaluant l’efficacité de l’AZD2281, en traitement de maitenance après au moins deux cures de chimiothérapie à base de platine, chez des patientes ayant un cancer de l’ovaire. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
Phase II randomised, double blind, multicentre study to assess the efficacy of AZD2281 in the treatment of patients with platinum sensitive serous ovarian cancer following treatment with two or more p...
Country
France
organs
Ovaire
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Astra ZenecaGmbH
Update Il y a 4 ans
CARE II - Evaluation of treatment outcomes in schizophrenic patients taking part in the integrated care program - a single-country, multi-centre phase IV study
Primary study objective is to assess the effect of quetiapine XR with or without concomitant participation in the ICP on the subjective well-being in patients treated for symptomatic schizophrenia, sc...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Astra Zeneca
Update Il y a 4 ans
Astra Zeneca HORIZON III : Essai de phase 2-3 randomisé, en double aveugle, comparant l’efficacité d’un traitement par cediranib à bévacizumab, associé à une chimiothérapie de type FOLFOX (5-fluorouracil, leucovorin et oxaliplatin) chez des patients ayant un cancer colorectal. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A randomised, double-blind, multicentre phase II/III study to compare the efficacy of cediranib (recentin™, AZD2171) in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX), to the ef...
Country
France
organs
Côlon ou Rectum (colorectal)
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Previous
1
2
3
4
5